KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 126 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is 1.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $8,605,000 | -45.3% | 114,773 | -45.1% | 0.00% | -40.0% |
Q2 2015 | $15,738,000 | +414.7% | 208,968 | +242.6% | 0.01% | – |
Q1 2015 | $3,058,000 | +467.3% | 60,995 | +292.7% | 0.00% | – |
Q4 2014 | $539,000 | -50.6% | 15,534 | -53.3% | 0.00% | – |
Q3 2014 | $1,090,000 | +121.1% | 33,286 | +158.9% | 0.00% | – |
Q2 2014 | $493,000 | +40.5% | 12,858 | +45.7% | 0.00% | – |
Q1 2014 | $351,000 | – | 8,827 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |